Abstract
Introduction

Alzheimer's disease (AD) is a neurodegenerative disease and the most common form of dementia which causes serious impairments of cognitive functions. The majority of AD cases in people over the age of 65 are of the sporadic (or 'late onset') form, suggesting that the disease has no family link. However, about 2-5% per cent of the Alzheimer population have 'familial' (FAD) or 'early onset' AD via autosomal dominant inheritance. FAD is identical to the sporadic form but it occurs because of the inheritance of certain genes which at some point in the family's history 'mutated' from having normal to abnormal characteristics. Most cases of FAD result from mutations in one of the three following genes: the amyloid precursor protein (APP), the presenilin 1 and 2 (PS1, PS2). All mutations result in elevated levels of amyloid-␤ (A␤)
peptide [1] . The most important genetic risk factor for both familial and sporadic forms of AD is the apoE4 gene [2, 3] . ApoE4 enhances the rate of amyloid fibril formation, interacts with the microtubule-associated proteins (MAPs) [4, 5] and directly affects cholinergic activity in the brains of AD patients [6] . Two studies esis but also by triggering degeneration [24] . Another mechanism for substrate degradation in eukaryotic cells is the proteasome. In neuritic plaques and tangles in brains of AD patients, the inhibition of the proteasome may result in neuronal death [25] . In addition, several studies have provided evidence implication of the oxidative stress as a major pathogenic mechanism in AD [26] .
In the last 8 years, works have focused on pathways of the control of translation, in particular the control of initiation [27] [28] [29] [30] . Our research works are related to these molecular signalling mechanisms to explain the neuronal death observed in AD.
In this review, we first describe the control of translation in eukaryotic cells before providing the current knowledge of the control of translation dysfunction in AD. We also examine the crosslink between disturbed PKR/eIF2␣ and mTOR/RS6K signalling pathways. Then, we discuss the choice of PKR as a biomarker of AD. [31, 32] [33, 34] thereby leads to the inhibition of translation [54] (Fig. 1) [68] and activating transcription factor 3 (ATF-3) [69] .
Control of translation
In eukaryotes, protein translation includes four consecutive phases: initiation, elongation, termination and ribosome recycling. The initiation phase corresponds to the connection between mRNA and ribosomes. The elongation phase includes the links between amino acids at the ribosomal level, and is followed by the termination phase at the level of stop codon and then by the dissociation of ribosomal subunits. All phases are regulated by proteins called translation factors, which can interact directly with mRNAs but most regulation is exerted at initiation where the start codon is identified and decoded by the methionyl tRNA specialized for initiation (Met-tRNAi). The process of initiation can be divided into three stages: (1) association of Met-tRNAi and several initiation factors with the 40S ribosomal subunit to form the 43S preinitiation complex (PIC); (2) the binding of this complex to mRNA, followed by its migration to the correct start codon and (3) the addition of the 60S ribosomal subunit to assemble an 80S ribosome at the initiation codon, ready for elongation
. In the first stage, the binary eukaryotic initiation factor (eIF)2-GDP complex requires eIF2B, a guanine nucleotide exchange factor to catalyse the regeneration of the eIF2-GTP complex for recruitment of the initiator tRNA and conduct it as a eIF2-GTP-Met-tRNAi ternary complex (TC),
The availability of the eIF4E factor is linked to the binding of specific proteins called 4E-BPs. When these proteins are nonphosphorylated, they have a great affinity for eIF4E, which is unable to bind the eIF4F complex, leading to the inhibition of the recognition of the mRNA 5Ј cap structure [70] , (Fig. 1) [71, 72] (Fig. 1) [75] [76] [77] (Fig. 1) . The regulation of mTOR activity is important for the availability of eIF4E. mTOR is activated by the phosphoinositide 3-kinase (PI3K) and protein kinase B (Akt/PKB) pathway [70] , (Fig. 1) [78] by blocking the small GTPase Rheb activity, which is a positive regulator of mTOR [79, 80] .
In addition, the reduction of eIF4E level is not enough to induce cellular apoptosis [81] and PKR can induce dephosphorylation of the proteins 4E-BPs by increasing the activity of the phosphatase 2A after its interaction with the regulatory subunit B56␣, leading to cell apoptosis [82] [83] [84] [85, 86] . Another signalling pathway is the Ras-MAPK pathway, which is responsible for the phosphorylation of eIF4E and eIF4B and strongly impacts translation [76] (Fig. 1) .
According to these results, it appears interesting to study these two pathways: PKR (pro-apoptotic) and mTOR (anti-apoptotic), involved in the control of initiation, in different models of neurodegenerative disorders and in AD patients. Both these molecular signalling pathways were largely described in AD. Studies have also reported that brain tissues from patients with Parkinson's and Huntington's diseases displayed strong induction of phosphorylated PKR in hippocampal neurons compared with age-matched disease controls [49].
Dysfunctions of protein synthesis mediated by PKR-and mTOR-dependent signalling pathways
It has been recognized for several years that the mRNA translation was disturbed in the brains of AD patients [87] . The inhibition of the ribosomal translation could be responsible for the modifications of gene expression detected in affected brain regions. An increased phosphorylation of the elongation factor 2 was also noted in the AD brains [88] .
For [92, 93] . The levels of the mTOR signalling markers were significantly and positively correlated with total and P- [92, 93] [106, 107] . Redd1 is a new stress-induced protein and is known as a negative regulator of mTOR through TSC1/TSC2 complex [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] . Redd1 appears to function in the regulation of cellular ROS, a pathway linked to both stress responses and modulation of growth factor signalling [110] . Data demonstrated that endogenous Redd1 is induced following energy stress and inhibition of endogenous Redd1 increases cell size in a rapamycin-sensitive manner [111] . The interaction between these factors and PKR was mainly described in IFN-treated [116, 117] . Furthermore, they showed that the exposure of non-AD fibroblasts to A␤40 peptide induced the expression of this unfolded p53 protein isoforms [118] . Same results were observed in human embryonic kidney cells stably transfected with wild-type APP 751 [119] . Other works showed that the expression of the conformationally altered p53 confers a higher resistance threshold to DNA damage by cytotoxic agents than in cells with the wild-type of p53 [119, 120] . Interestingly, PKR activates GSK-3␤, which phosphorylates p53 in nucleus and promotes the proteasomal degradation of p53 by the Hdm2-dependent ubiquitination [121] . Furthermore, authors showed that the down-regulation of p53 by double-stranded RNA was not a consequence of apoptosis but rather seemed to sensitize cells to death [122] .
]). Other studies showed significant increases of Pp70S6K (T389 and T421/S424), P-mTOR (S2481), P-eIF4E and P-4E-BP1 (T70 and S65) in homogenates of the medial temporal cortex in AD patients as compared to control brains
p53 can also interrupt the proliferation by detecting abnormal ribosomal biogenesis [123] . In AD, the ribogenesis is altered in apoptotic neurons [27, 91, 124] . Interestingly, p53 is able to inhibit the activity of mTOR through TSC1/TSC2 complex [105] . [128] . Recently, we showed that the transfection of PKR siRNA to A␤42-treated SH-SY5Y cells significantly decreased the p66 isoform of p53, the transcriptional expression of Redd1 and increased the levels of phosphorylated TSC2 [129] .
It is well known that 14-3-3 proteins bind TSC2 protein and this interaction is dependent of the TSC2 phosphorylation and negatively regulates TSC2 [125, 126]. A recent study showed that endogenous Redd1 is required for both dissociation of endogenous TSC2/14-3-3 proteins and inhibition of mTOR in response to hypoxia [127]. In fact, Redd1 can bind 14-3-3 proteins and so releases TSC2 which is dephosphorylated to inhibit the mTOR activity. Authors showed that the antisense Redd1 gene protected the cells from A␤ neurotoxicity
Besides, it is known that the neuronal cell cycle regulatory failure, leading to apoptosis, may be a significant component of the pathogenesis of AD [130] [131] [132] [135] [101, 118, 124, [140] [141] [142] [143] [144] . Ray et al. [145] [50, 95] . In addition, we reported that PKR represents an initiator of deregulated translation via two consecutive targets p53 and Redd1 in AD lymphocytes [102] . However, our data showed that the number of mononuclear cells was significantly higher (43%) in AD patients than in controls. These results are in accordance with other studies [146, 147] . Paradoxically, the up-regulation of PKR in mononuclear cells do not lead to the cell death observed in cellular models exposed to A␤, in AD transgenic mice and in brains of AD patients [50, 95, 97] . With all these data, we can propose some hypotheses for cellular paradox between neurons and lymphocytes in AD (Fig. 3) . First, expression of the conformationaly altered p53 could confer a higher resistance to the activated PKR signalling pathway. Second, Akt signalling pathway is up-regulated in lymphocytes [148] . Third, mTOR suppresses caspase-1 activation and orchestrates the defence programme of innate immune cells [149] . Finally, inflammatory mechanisms represent an important component which, first contribute to defence mechanisms but secondly, stimulated by degeneration, may significantly contribute to disease progression and chronicity [15, 150, 151] [152, 153] [154] [155] [156] . Recently, it was demonstrated that a blockade of TNF-␣ production at the periphery prevented histological lesions induced by IL-1␤ in CNS [157] .
. Many studies showed the expression of a repertoire of proteins in neurons involved in the control of cell cycle until the phase G2 with the expression of the cyclin B1 for the maturation promoting factor in order to re-enter the cell cycle [133-137]. However, little is known about the possible causes of the neuronal cell cycle re-entry and its subsequent regulatory failure. In neurons that express high levels of Bax (apoptotic mRNA transcriptionally activated by p53), the G2 arrest will lead to apoptosis and in neuronal populations that are not-apoptosis competent, a prolonged G2 arrest could lead to the development of AD-type pathology with hyperphosphorylation of controlling by various cell cycle kinases
. Besides the local innate immunity of the central nervous system (CNS) including the activation of microglia and astrocytes, the involvement of complement factors, pro-inflammatory cytokines and chemokines, increased studies suggest that systemic immune response, including T-cell immune response, may be involved in the inflammation process of AD
. Peripheral T cells could exert their effects on the AD process without entering the CNS. Either T cells secrete cytokines such as IFN-␥ on activation, and that such pro-inflammatory cytokines enter the CNS and activate microglia and astrocytes, or peripheral activated T cells promote activation of myeloid cells such as monocytes, macrophages and dendritic cells that secrete pro-inflammatory cytokines such as tumour necrosis factor (TNF)-␣, interleukin (IL)-1␤ and IL-6. In fact, there is some evidence of elevated IL-6 levels in monocytes derived from AD patients
Furthermore, activated T cells also exist as infiltrates in the brains of AD patients [158] [159] [160] [164, 165] Fig. 2 Crosslink between PKR-and mTORdependent signalling pathways in apoptotic neurons in AD.
. In vitro data showed a 'cross-talking' between microglia and T cells, microglia can serve as antigenpresenting cells for A␤-reactive T cells and, in turn, T cells themselves can influence microglial differentiation [161-163]. Different types of T cells would be expected to have different effects on microglial cell activation and therefore on amyloid clearance. Thelper 1 cells can promote microglial cell activation through the secretion of IFN-␥, which also up-regulates the expression major histocompatibility complex class II molecules by microglial cells, thereby enhancing the interaction between T cells and microglial cells
. A study has shown that the interaction of CD40 (expressed on the surface of microglia) and CD40L (T-cell receptor) promotes pro-inflammatory microglial cell activation in
Fig. 3 Paradoxal effect of active PKR in neurons and lymphocytes in AD.
response to A␤ [166] . Furthermore, recent evidence revealed that peripheral T cells of AD patients overexpressed CXCR2 (CXC chemokine receptor 2), which is intracerebral microglial TNF-␣-dependent and is associated with T-cell adhesion on brain endothelia and transendothelial migration [167] . It is also known that glial cells can mediate the permeability of blood brain barrier to recruit specialized immune cells from the periphery such as T cells [164] .
Besides these roles of peripheral immune cells in AD brains, further studies would be investigated to understand deeply the interactions between glia and peripheral immune cells. These researches may reveal new targets modulating brain inflammation and help in developing novel immunotherapeutic approaches to AD.
Nevertheless, despite these several defence mechanisms, authors showed a cell cycle regulatory failure in lymphocytes as it was observed in neurons [130-132, 168, 169] .
PKR is not specific to AD because it is also known to be active in other neurodegenerative diseases like Parkinson's disease [49, 170] , Huntington's disease [48] and amyotrophic lateral sclerosis [96] . PKR is not specific to neurodegenerative disease because it is also implied in infectious [61, 171] , inflammatory [172, 173] and ischemic [171] [97] . At present, there are five major effectors, eIF2␣, FADD, p53, NF-B and ATF-3 implicated in mediating PKR-induced apoptosis [171] . In AD, eIF2␣ and p53 are targets of PKR [28, 30, 97, 102, 129] . NF-B and ATF-3 activation by PKR is also involved in apoptosis induction as shown in virus-infected cells [69, [174] [175] [176] . However, NF-B could be under the control of PKR in AD because this factor is activated in AD [177, 178] . In addition, FADD and the subsequent caspase-8 are responsible for PKR-induced apoptosis in virus-infected cells [179] and an overexpression of a dominantnegative FADD construct rescued SH-SY5Y cells from either TNFrelated apoptosis-inducing ligand or A␤-induced neurotoxicity [180] 
Conclusion and perspectives
In conclusion, data revealed that PKR can represent an initiator of the dysfunction of the control of translation described in AD. In the brain, this disturbance is associated with the neuronal death while in peripheral mononuclear cells of AD patients, PKR can control the cell cycle and the inflammatory reaction. In brains of APPSL/PS1 KI mice, PKR was early up-regulated before the massive neuronal loss [97] . In patients, the PKR levels were correlated to the severity of the disease [101] 
